A Study in Non Small Cell Lung Cancer

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
9255
Conditions: Non Small Cell Lung Cancer
Start Date: December 1, 2010
Phase: Phase I|Phase II
Status: Not yet recruiting
NCT ID: NCT01139775
Study Type: Interventional
Intervention: Drug: Pemetrexed|Drug: Cisplatin|Drug: LY2603618
Study Design: Allocation: Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: Eli Lilly and Company
Ages: Adult|Senior
Enrollment: 64
Funded By: Industry
First Received: June 1, 2010
End Date: March 1, 2014
Last Updated: December 6, 2010
Last Verified: December 1, 2010